nationalpost.com
Big pharma might cut research, delay new drugs if pharmacare means more generics: memo
Beyond the risk of missing out on investment dollars, Fralick said if unfriendly conditions encourage companies to look elsewhere, new drugs could be delayed years before they get to Canada